Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Peripheral arterial intervention · Florida | Peripheral arterial intervention · Texas | |
|---|---|---|
| Surgeons, 2024 | 132 | 128 |
| Medicare fee-for-service cases | 20,074 | 16,813 |
| Growth since 2019 (Medicare FFS) | −3.1%/yr | −7.6%/yr |
| Forecast cases (Medicare FFS) | 23,800 in 2030 | 19,600 in 2030 |
| Forecast growth | +2.9%/yr to 2030 | +2.6%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 8.5 | 7.4 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 70% (+7 pts since 2019) | 58% (+6 pts since 2019) |
| Cases per surgeon | 152 | 131 |
| Top 10 surgeons' share | 42% | 31% |
| Surgeons growing | 30 | 18 |
| New since the base year | 16 | 19 |
| Likely to stop billing it | 21 by 2026 | 21 by 2026 |
| Forecast miss, 1 year (procedure) | 8% | 8% |
| Company payments per surgeon | $4,937 | $1,503 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.